This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Diodato D, Melchionda L, Haack TB, Dallabona C, Baruffini E, Donnini C, et al. VARS2 and TARS2 mutations in patients with mitochondrial encephalomyopathies. Hum Mutat. 2014; 35(8):983–9.DiodatoDMelchiondaLHaackTBDallabonaCBaruffiniEDonniniCVARS2 and TARS2 mutations in patients with mitochondrial encephalomyopathiesHum Mutat20143589839Search in Google Scholar
Accogli A, Lin SJ, Severino M, Kim SH, Huang K, Rocca C, et al. Clinical, neuroradiological, and molecular characterization of mitochondrial threonyltRNA-synthetase (TARS2)-related disorder. Genet Med. 2023; 25(11):100938.AccogliALinSJSeverinoMKimSHHuangKRoccaCClinical, neuroradiological, and molecular characterization of mitochondrial threonyltRNA-synthetase (TARS2)-related disorderGenet Med20232511100938Search in Google Scholar
He P, Wang Q, Hong X, Yuan H. Novel TARS2 variant identified in a Chinese patient with mitochondrial encephalomyopathy and a systematic review. Am J Med Genet A. 2023; 191(1):70–6.HePWangQHongXYuanHNovel TARS2 variant identified in a Chinese patient with mitochondrial encephalomyopathy and a systematic reviewAm J Med Genet A20231911706Search in Google Scholar
Zheng WQ, Pedersen SV, Thompson K, Bellacchio E, French CE, Munro B, et al. Elucidating the molecular mechanisms associated with TARS2-related mitochondrial disease. Hum Mol Genet. 2022; 31(4):523–34.ZhengWQPedersenSVThompsonKBellacchioEFrenchCEMunroBElucidating the molecular mechanisms associated with TARS2-related mitochondrial diseaseHum Mol Genet202231452334Search in Google Scholar
Li X, Peng B, Hou C, Li J, Zeng Y, Wu W, Liao Y, et al. Novel compound heterozygous TARS2 variants in a Chinese family with mitochondrial encephalomyopathy: a case report. BMC Med Genet. 2020; 21(1):217.LiXPengBHouCLiJZengYWuWLiaoYNovel compound heterozygous TARS2 variants in a Chinese family with mitochondrial encephalomyopathy: a case reportBMC Med Genet2020211217Search in Google Scholar
Parasyri M, Brandström P, Uusimaa J, Ostergaard E, Hikmat O, Isohanni P, et al. Renal Phenotype in Mitochondrial Diseases: A Multicenter Study. Kidney Dis (Basel). 2022; 8(2):148–59.ParasyriMBrandströmPUusimaaJOstergaardEHikmatOIsohanniPRenal Phenotype in Mitochondrial Diseases: A Multicenter StudyKidney Dis (Basel)20228214859Search in Google Scholar
Finsterer J, Scorza FA. Renal manifestations of primary mitochondrial disorders. Biomed Rep. 2017; 6(5):487–94.FinstererJScorzaFARenal manifestations of primary mitochondrial disordersBiomed Rep20176548794Search in Google Scholar
O’Toole JF. Renal manifestations of genetic mitochondrial disease. Int J Nephrol Renovasc Dis. 2014; 7:57–67.O’TooleJFRenal manifestations of genetic mitochondrial diseaseInt J Nephrol Renovasc Dis201475767Search in Google Scholar
Rahman S, Hall AM. Mitochondrial disease: an important cause of end-stage renal failure. Pediatr Nephrol. 2013; 28(3):357–61.RahmanSHallAMMitochondrial disease: an important cause of end-stage renal failurePediatr Nephrol201328335761Search in Google Scholar
Govers LP, Toka HR, Hariri A, Walsh SB, Bockenhauer D. Mitochondrial DNA mutations in renal disease: an overview. Pediatr Nephrol. 2021; 36(1):9–17.GoversLPTokaHRHaririAWalshSBBockenhauerDMitochondrial DNA mutations in renal disease: an overviewPediatr Nephrol2021361917Search in Google Scholar
Belostotsky R, Ben-Shalom E, Rinat C, et al. Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome. Am J Hum Genet. 2011; 88:193–200.BelostotskyRBen-ShalomERinatCMutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndromeAm J Hum Genet201188193200Search in Google Scholar
D’Aco KE, Manno M, Clarke C, Ganesh J, Meyers KE, Sondheimer N. Mitochondrial tRNA(Phe) mutation as a cause of end-stage renal disease in childhood. Pediatr Nephrol. 2013; 28(3):515–9.D’AcoKEMannoMClarkeCGaneshJMeyersKESondheimerNMitochondrial tRNA(Phe) mutation as a cause of end-stage renal disease in childhoodPediatr Nephrol20132835159Search in Google Scholar
Al-Gadi IS, Haas RH, Falk MJ, Goldstein A, McCormack SE. Endocrine Disorders in Primary Mitochondrial Disease. J Endocr Soc. 2018; 2(4):361–73.Al-GadiISHaasRHFalkMJGoldsteinAMcCormackSEEndocrine Disorders in Primary Mitochondrial DiseaseJ Endocr Soc20182436173Search in Google Scholar
Ng YS, Lim AZ, Panagiotou G, Turnbull DM, Walker M. Endocrine Manifestations and New Developments in Mitochondrial Disease. Endocr Rev. 2022; 43(3):583–609.NgYSLimAZPanagiotouGTurnbullDMWalkerMEndocrine Manifestations and New Developments in Mitochondrial DiseaseEndocr Rev2022433583609Search in Google Scholar